Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nau

Showing results (121-130 of 317) with videos related to

Pageof 32
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytesA Lampen, S Meyer, T Arnhold, et al.
Developmental Pharmacology and Therapeutics|January 1, 1990
Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapyB Löfberg, J Reiners, H Spielmann, et al.
Teratology|June 1, 1990
Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral doseB Löfberg, I Chahoud, G Bochert, et al.
Environmental Health Perspectives|December 1, 1994
Pharmacokinetic determinants of embryotoxicity in rats associated with organic acidsW J Scott, M D Collins, H Nau
Biopharmaceutics & Drug Disposition|April 1, 1983
Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirsH Nau, P Finley, J Williams, et al.
Die Naturwissenschaften|June 1, 1991
On the development of alternative antiepileptic drugs. Lack of enantioselectivity of the anticonvulsant activity, in contrast to teratogenicity, of 2-n-propyl-4-pentenoic acid and 2-n-propyl-4-pentynoic acid, analogues of the anticonvulsant drug valproic acidR S Hauck, H Nau, M M Elmazar
Journal of Chromatography|September 1, 1978
Quantitative analysis of prazepam and its metabolites by electron capture gas chromatography and selected ion monitoring. Application to diaplacetal passage and fetal hepatic metabolism in early human pregnancyH Nau, C Liddiard, D Jesdinsky, et al.
FEBS Letters|April 8, 1996
Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidationG S Baldwin, F S Abbott, H Nau
Archives of Toxicology|April 1, 1986
Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in cultureC Lewandowski, S Klug, H Nau, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 13, 2010
Pharmacokinetic aspects of drug effects in vitro (II) placental transfer to the embryo and activity of some carboxylic acids structurally related to valproic acid in whole embryos in cultureH Nau, C Lewandowski, S Klug, et al.
Pageof 32

Showing results (121-130 of 317) with videos related to

Sort By:
Pageof 32
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytesA Lampen, S Meyer, T Arnhold, et al.
Developmental Pharmacology and Therapeutics|January 1, 1990
Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapyB Löfberg, J Reiners, H Spielmann, et al.
Teratology|June 1, 1990
Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral doseB Löfberg, I Chahoud, G Bochert, et al.
Environmental Health Perspectives|December 1, 1994
Pharmacokinetic determinants of embryotoxicity in rats associated with organic acidsW J Scott, M D Collins, H Nau
Biopharmaceutics & Drug Disposition|April 1, 1983
Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirsH Nau, P Finley, J Williams, et al.
Die Naturwissenschaften|June 1, 1991
On the development of alternative antiepileptic drugs. Lack of enantioselectivity of the anticonvulsant activity, in contrast to teratogenicity, of 2-n-propyl-4-pentenoic acid and 2-n-propyl-4-pentynoic acid, analogues of the anticonvulsant drug valproic acidR S Hauck, H Nau, M M Elmazar
Journal of Chromatography|September 1, 1978
Quantitative analysis of prazepam and its metabolites by electron capture gas chromatography and selected ion monitoring. Application to diaplacetal passage and fetal hepatic metabolism in early human pregnancyH Nau, C Liddiard, D Jesdinsky, et al.
FEBS Letters|April 8, 1996
Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidationG S Baldwin, F S Abbott, H Nau
Archives of Toxicology|April 1, 1986
Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in cultureC Lewandowski, S Klug, H Nau, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 13, 2010
Pharmacokinetic aspects of drug effects in vitro (II) placental transfer to the embryo and activity of some carboxylic acids structurally related to valproic acid in whole embryos in cultureH Nau, C Lewandowski, S Klug, et al.
Pageof 32